{
  "trial_id": "NCT01822925",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, type of diabetes (Type I or Type II), HbA1c levels, duration of diabetic neuropathic pain, baseline pain score, BMI, cognitive and communicative ability, pregnancy status, history of drug or alcohol abuse, presence of other medical conditions, laboratory blood biochemistry results, HIV status, NYHA class for congestive heart failure, use of birth control methods, psychiatric disorder diagnosis, use of local anesthetics or systemic steroids, willingness to undergo washout period.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Body Mass Index (BMI)",
          "BMI"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment",
        "Height",
        "Weight"
      ],
      "remaining_candidate_features": [
        "type of diabetes (Type I or Type II)",
        "HbA1c levels",
        "duration of diabetic neuropathic pain",
        "baseline pain score",
        "cognitive and communicative ability",
        "pregnancy status",
        "history of drug or alcohol abuse",
        "presence of other medical conditions",
        "laboratory blood biochemistry results",
        "HIV status",
        "NYHA class for congestive heart failure",
        "use of birth control methods",
        "psychiatric disorder diagnosis",
        "use of local anesthetics or systemic steroids",
        "willingness to undergo washout period."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diabetes Type, HbA1c, Duration of Diabetic Neuropathy, Baseline Pain Score, BMI, Concomitant Medications, ",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Body Mass Index (BMI)",
          "BMI"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Height",
        "Weight"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Diabetes Type",
        "HbA1c",
        "Duration of Diabetic Neuropathy",
        "Baseline Pain Score",
        "Concomitant Medications"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diabetes Type, HbA1c, BMI, Duration of Diabetic Neuropathy, Average Pain Score at Baseline, History of Cardiovascular Disease.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Body Mass Index (BMI)",
          "BMI"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Height",
        "Weight"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Diabetes Type",
        "HbA1c",
        "Duration of Diabetic Neuropathy",
        "Average Pain Score at Baseline",
        "History of Cardiovascular Disease."
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, weight, height, BMI, HbA1c, duration of diabetes, duration of diabetic neuropathic pain, average pain score at baseline, type of diabetes (I or II), use of pain medications at baseline, cognitive and communicative ability, medical history (including presence of comorbidities).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Body Mass Index (BMI)",
          "BMI"
        ],
        [
          "Height",
          "height"
        ],
        [
          "Weight",
          "weight"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "HbA1c",
        "duration of diabetes",
        "duration of diabetic neuropathic pain",
        "average pain score at baseline",
        "type of diabetes (I or II)",
        "use of pain medications at baseline",
        "cognitive and communicative ability",
        "medical history (including presence of comorbidities)"
      ]
    }
  }
}